2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
32
Pain, Postoperative
18
Neoplasms
16
Parkinson Disease 4, Autosomal Dominant Lewy Body
13
Lung Neoplasms
12
Brain Neoplasms
12
Prostatic Neoplasms
9
Ovarian Neoplasms
9
Colonic Neoplasms
8
Carcinoma, Hepatocellular
8
Stomach Neoplasms
7
Depression
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Pain
6
Head and Neck Neoplasms
6
Thyroid Neoplasms
5
Pancreatic Neoplasms
5
Multiple Myeloma
5
Leiomyoma
5
Agnosia
5
Neoplasm Metastasis
4
Lymphoma
4
Fatigue
4
Delirium
4
Anxiety Disorders
4
Urinary Bladder Neoplasms
3
Thromboembolism
3
Supratentorial Neoplasms
3
Stomatitis
3
Interventions
pembrolizumab
29
avelumab
21
Nivolumab
20
Ipilimumab
10
Radiotherapy
9
Cyclophosphamide
9
atezolizumab
8
cemiplimab
7
fludarabine
6
Specimen Handling
6
durvalumab
5
aldesleukin
5
Radiation
5
Magnetic Resonance Spectroscopy
5
Interleukin-2
5
Biopsy
5
talimogene laherparepvec
4
ALT-803
4
poly ICLC
3
Radiosurgery
3
Etoposide
3
Cisplatin
3
Carboplatin
3
CTLA-4 Antigen
3
Bevacizumab
3
prednylidene
2
lutetium Lu 177 dotatate
2
fludarabine phosphate
2
domatinostat
2
deltacortene
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Merkel Cell
×
Saline Solution
×
Clear all
NCT03271372
2026-05-12
ADAM
University of Washington
Phase 3
Active not recruiting
101 enrolled